The Queen Elizabeth Hospital in Kota Kinabalu, Sabah is the main hospital for the city and the whole of Sabah as well as the alternate feeder general hospital for the neighbouring Federal Territory of ...

During the past decade, Hospital Queen Elizabeth conducted 31 clinical trials. In the 10-year time frame, 31 clinical trials started and 10 clinical trials were completed, i.e. on average, 32.3% percent of trials that started reached the finish line to date. In the past 5 years, 14 clinical trials started and 6 clinical trials were completed. i.e. 42.9% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hospital Queen Elizabeth" #1 sponsor was "Janssen Research & Development, LLC" with 5 trials, followed by "Ministry of Health, Malaysia" with 4 trials sponsored, "Galapagos NV" with 3 trials sponsored, "Agios Pharmaceuticals, Inc." with 2 trials sponsored and "Boehringer Ingelheim" with 2 trials sponsored. Other sponsors include 17 different institutions and companies that sponsored additional 22 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital Queen Elizabeth" #1 collaborator was "Gilead Sciences" with 3 trials as a collaborator, "Hospital Queen Elizabeth, Malaysia" with 3 trials as a collaborator, "Kuala Lumpur General Hospital" with 3 trials as a collaborator, "Hospital Enche Besar Hajjah Khalsom, Kluang, Johor" with 2 trials as a collaborator and "Hospital Melaka, Melaka" with 2 trials as a collaborator. Other collaborators include 28 different institutions and companies that were collaborators in the rest 29 trials.

According to Clinical.Site data, the most researched conditions in "Hospital Queen Elizabeth" are "Anosmia" (2 trials), "COVID-19" (2 trials), "Crohn's Disease" (2 trials), "Dysgeusia" (2 trials) and "Erosive Esophagitis" (2 trials). Many other conditions were trialed in "Hospital Queen Elizabeth" in a lesser frequency.

Most popular intervention types in "Hospital Queen Elizabeth" are "Drug" (30 trials), "Other" (7 trials), "Biological" (1 trials) and "Diagnostic Test" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (8 trials), "Filgotinib" (4 trials), "Bortezomib" (2 trials), "Lansoprazole" (2 trials) and "Lansoprazole Placebo" (2 trials). Other intervention names were less common.

The vast majority of trials in "Hospital Queen Elizabeth" are 38 trials for "All" genders.

Currently, there are NaN active trials in "Hospital Queen Elizabeth". undefined are not yet recruiting, 11 are recruiting, 4 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 16 completed trials in Hospital Queen Elizabeth, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Hospital Queen Elizabeth, 0 "Phase 1" clinical trials were conducted, 9 "Phase 2" clinical trials and 23 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 2 trials that are defined as “Not Applicable".